eBioscience, Inc., An Affymetrix (Santa Clara, California) Business, Launches The First Assay To Detect RNA And Protein Simultaneously In Millions Of Single Cells

SANTA CLARA, Calif.--(BUSINESS WIRE)--eBioscience, an Affymetrix (Nasdaq:AFFX) business, announces the availability of PrimeFlow™ RNA Assay, the first and only flow cytometry assay capable of simultaneous detection of RNA and protein within millions of cells at single-cell resolution. Current flow cytometry applications are limited to antibody-based interrogation of cell surface and intracellular proteins. With the novel PrimeFlow assay, researchers can now incorporate the simultaneous analysis of RNA transcripts and proteins to elevate their understanding of single-cell dynamics.

Help employers find you! Check out all the jobs and post your resume.

Back to news